{"name":"Cabergoline","slug":"cabergoline","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Dostinex","Cabaser","Cabergolina","Cabergolinum","Fce-21336","Velactis","Fce 21336","1-((6-Allylergolin-8β-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea","1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'β-carbonyl)urea","1-[(6-allylergoline-8β-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea"],"brands":[],"scraped":true,"has_structure":true,"cid":54746,"classes":[],"families":[{"name":"ergoline","href":"/substituted/ergoline"},{"name":"lysergamide","href":"/substituted/lysergamide"}],"physical":[{"label":"Molecular mass","value":"451.60 g/mol","copyable":false},{"label":"Melting point","value":"102-104 °C","copyable":false},{"label":"Solubility","value":"Insoluble","copyable":false},{"label":"Predicted LogP","value":"3.4","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>26</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","copyable":true},{"label":"SMILES","value":"CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C","copyable":true},{"label":"InChI","value":"InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1","copyable":true},{"label":"InChIKey","value":"KORNTPPJEAJQIU-KJXAQDMKSA-N","copyable":true},{"label":"CAS number","value":"81409-90-7","copyable":true},{"label":"UNII","value":"LL60K9J05T","copyable":true},{"label":"PubChem CID","value":"54746","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"63–69 hours (estimated)","copyable":false},{"label":"Metabolism","value":"Liver, predominately via hydrolysis of the acylurea bond or the urea moiety","copyable":false},{"label":"Excretion","value":"Urine (22%), feces (60%)","copyable":false},{"label":"Routes of administration","value":"Oral","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"G","description":"Genito urinary system and sex hormones"},{"code":"G02","description":"Other gynecologicals"},{"code":"G02C","description":"Other gynecologicals"},{"code":"G02CB","description":"Prolactine inhibitors"},{"code":"G02CB03","description":""},{"code":"G02CB03","description":"Cabergoline"},{"code":"N","description":"Nervous system"},{"code":"N04","description":"Anti-parkinson drugs"},{"code":"N04B","description":"Dopaminergic agents"},{"code":"N04BC","description":"Dopamine agonists"},{"code":"N04BC06","description":"Cabergoline"},{"code":"N04BC06; G02CB03","description":""}],"mesh":[{"name":"Antiparkinson Agents","id":"M0001494"},{"name":"Dopamine Agonists","id":"M0027733"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"DRD2","mechanisms":["shared target"],"partners":150,"contraindicated":0},{"target":"CYP3A4","mechanisms":["metabolism","induction","inhibition"],"partners":106,"contraindicated":1},{"target":"PRL","mechanisms":["shared target"],"partners":1,"contraindicated":0}],"mechanism":"The dopamine D<sub>2</sub> receptor is a 7-transmembrane G-protein coupled receptor associated with G<sub>i</sub> proteins. In lactotrophs, stimulation of dopamine D<sub>2</sub> causes inhibition of adenylyl cyclase, which decreases intracellular cAMP concentrations and blocks IP3-dependent release of Ca<sup>2+</sup> from intracellular stores. Decreases in intracellular calcium levels may also be brought about via inhibition of calcium influx through voltage-gated calcium channels, rather than via inhibition of adenylyl cyclase. Additionally, receptor activation blocks phosphorylation of p42/p44 MAPK and decreases MAPK/ERK kinase phosphorylation. Inhibition of MAPK appears to be mediated by c-Raf and B-Raf-dependent inhibition of MAPK/ERK kinase. Dopamine-stimulated growth hormone release from the pituitary gland is mediated by a decrease in intracellular calcium influx through voltage-gated calcium channels rather than via adenylyl cyclase inhibition. Stimulation of dopamine D<sub>2</sub> receptors in the nigrostriatal pathway leads to improvements in coordinated muscle activity in those with movement disorders. Cabergoline is a long-acting dopamine receptor agonist with a high affinity for D2 receptors. Receptor-binding studies indicate that cabergoline has low affinity for dopamine D1, &alpha;<sub>1</sub>,- and &alpha;<sub>2</sub>- adrenergic, and 5-HT<sub>1</sub>- and 5-HT<sub>2</sub>-serotonin receptors.","side_effects":{"drug_id":2512,"drug_name":"cabergoline","url":"https://sideeffects.embl.de/drugs/2512/pt","atc_codes":["G02CB03","N04BC06"],"side_effects":[{"name":"Nausea","cui":"C0027497"},{"name":"Headache","cui":"C0018681"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Lightheadedness","cui":"C0220870"},{"name":"Constipation","cui":"C0009806"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Dyskinesia","cui":"C0013384"},{"name":"Influenza","cui":"C0021400"},{"name":"Gastritis","cui":"C0017152"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Hallucination","cui":"C0018524"},{"name":"Sleep disorder","cui":"C0851578"},{"name":"Bronchitis","cui":"C0006277"},{"name":"Back pain","cui":"C0004604"},{"name":"Urinary tract infection","cui":"C0042029"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Hypertension","cui":"C0020538"},{"name":"Oedema peripheral","cui":"C0085649"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Upper respiratory tract infection","cui":"C0041912"},{"name":"Euphoric mood","cui":"C0235146"},{"name":"Hypokinesia","cui":"C0086439"},{"name":"Nightmare","cui":"C0028084"},{"name":"Pneumonia","cui":"C0032285"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Malaise","cui":"C0231218"},{"name":"Vertigo","cui":"C0042571"},{"name":"Vomiting","cui":"C0042963"},{"name":"Arthropathy","cui":"C0022408"},{"name":"Osteoarthritis","cui":"C0029408"},{"name":"Orthostatic hypotension","cui":"C0020651"},{"name":"Prostatic disorder","cui":"C0033575"},{"name":"Depression","cui":"C0011570"},{"name":"Pain","cui":"C0030193"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Breast pain","cui":"C0024902"},{"name":"Breast pain female","cui":"C0553713"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Somnolence","cui":"C2830004"},{"name":"Excessive daytime sleepiness","cui":"C0694563"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Palpitations","cui":"C0030252"},{"name":"Flatulence","cui":"C0016204"},{"name":"Hypotension","cui":"C0020649"},{"name":"Hypotensive","cui":"C0857353"},{"name":"Hypotension symptomatic","cui":"C0863113"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Anxiety","cui":"C0003467"},{"name":"Insomnia","cui":"C0917801"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Menopausal symptoms","cui":"C0236075"},{"name":"Hot flush","cui":"C0600142"},{"name":"Dysmenorrhoea","cui":"C0013390"},{"name":"Pruritus","cui":"C0033774"},{"name":"Gravitational oedema","cui":"C0235437"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Rhinitis","cui":"C0035455"},{"name":"Disturbance in attention","cui":"C0233414"},{"name":"Mental disability","cui":"C1306341"},{"name":"Visual impairment","cui":"C3665347"},{"name":"Periorbital oedema","cui":"C0151205"},{"name":"Acne","cui":"C0702166"},{"name":"Toothache","cui":"C0040460"},{"name":"Discomfort","cui":"C0234215"},{"name":"Ill-defined disorder","cui":"C2047937"},{"name":"Influenza like illness","cui":"C0521839"},{"name":"Throat irritation","cui":"C0700184"},{"name":"Aggression","cui":"C0001807"},{"name":"Alopecia","cui":"C0002170"},{"name":"Delusion","cui":"C0011253"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Oedema","cui":"C0013604"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Fibrosis","cui":"C0016059"},{"name":"Cardiac valve disease","cui":"C0018824"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Impulse-control disorder","cui":"C0021122"},{"name":"Libido increased","cui":"C0021177"},{"name":"Disturbance in sexual arousal","cui":"C0855242"},{"name":"Muscle spasms","cui":"C0037763"},{"name":"Pathological gambling","cui":"C0030662"},{"name":"Pericardial effusion","cui":"C0031039"},{"name":"Pericarditis","cui":"C0031046"},{"name":"Pleural effusion","cui":"C0032227"},{"name":"Pleurisy","cui":"C0032231"},{"name":"Psychotic disorder","cui":"C0033975"},{"name":"Pulmonary fibrosis","cui":"C0034069"},{"name":"Retroperitoneal fibrosis","cui":"C0035357"},{"name":"Vasospasm","cui":"C0085616"},{"name":"Hepatic function abnormal","cui":"C0086565"},{"name":"Liver function test abnormal","cui":"C0151766"},{"name":"Blood creatinine increased","cui":"C0235431"},{"name":"Hypersexuality","cui":"C0312420"},{"name":"Respiratory failure","cui":"C1145670"},{"name":"Regurgitation","cui":"C2004489"},{"name":"Pleural fibrosis","cui":"C2720436"},{"name":"Congenital anomaly","cui":"C0000768"},{"name":"Developmental delay","cui":"C0424605"},{"name":"Arrhythmia","cui":"C0003811"},{"name":"Neoplasm malignant","cui":"C0006826"},{"name":"Duodenal ulcer","cui":"C0013295"},{"name":"Epistaxis","cui":"C0014591"},{"name":"Cardiac disorder","cui":"C0018799"},{"name":"Cardiac failure","cui":"C0018801"},{"name":"Hemianopia","cui":"C0018979"},{"name":"Musculoskeletal pain","cui":"C0026858"},{"name":"Nasal congestion","cui":"C0027424"},{"name":"Pericarditis constrictive","cui":"C0031048"},{"name":"Congenital genitourinary abnormality","cui":"C0042063"},{"name":"Weight increased","cui":"C0043094"},{"name":"Weight decreased","cui":"C0043096"},{"name":"Abdominal pain upper","cui":"C0232492"},{"name":"Abdominal discomfort","cui":"C0232487"},{"name":"Face oedema","cui":"C0542571"},{"name":"Sudden onset of sleep","cui":"C0919582"}],"indications":[{"name":"Amenorrhoea","cui":"C0002453"},{"name":"Anovulation","cui":"C0003128"},{"name":"Breast feeding","cui":"C0006147"},{"name":"Cleft lip","cui":"C0008924"},{"name":"Death neonatal","cui":"C0410916"},{"name":"Empty sella syndrome","cui":"C0014008"},{"name":"Galactorrhoea","cui":"C0235660"},{"name":"Hyperprolactinaemia","cui":"C0020514"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Oligomenorrhoea","cui":"C0028949"},{"name":"Parkinson's disease","cui":"C0030567"},{"name":"Pituitary adenoma","cui":"C0032000"},{"name":"Pituitary tumour","cui":"C0032019"},{"name":"Prolactinoma","cui":"C0033375"},{"name":"Stillbirth","cui":"C0595939"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[3]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Cabergoline"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/54746"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q423308"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00248"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1201087"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A3286"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=81409-90-7"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014393"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C08187"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID6022719"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Cabergoline"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/LL60K9J05T"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/2512/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 54746, Cabergoline. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/54746>https://pubchem.ncbi.nlm.nih.gov/compound/54746</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cabergoline. UNII: LL60K9J05T. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/LL60K9J05T>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/LL60K9J05T</a>","Carbelin (Nova Pharmaceuticals Australasia Pty Ltd). Therapeutic Goods Administration (TGA). 13 September 2024. <a href='https://www.tga.gov.au/resources/prescription-medicines-registrations/carbelin-nova-pharmaceuticals-australasia-pty-ltd'>https://www.tga.gov.au/resources/prescription-medicines-registrations/carbelin-nova-pharmaceuticals-australasia-pty-ltd</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 03:05:44","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 03:05:40","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 03:05:40","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 03:05:40","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 03:05:40","note":"hmdb.ca refused automated access to HMDB0014393"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 03:05:42","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 03:05:40","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 03:05:40","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 03:05:40","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 03:05:40","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 03:05:40","note":null}],"description":"Cabergoline is a  substance."}